Clinical trial
Efficacy and Safety of Low-dose Tolvaptan in Treatment of Inpatient Hyponatraemia.
NCT06171100 is registered in ClinicalTrials.gov with King's College Hospital NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Low-dose Tolvaptan in Treatment of Inpatient Hyponatraemia.
- Lead sponsor
- King's College Hospital NHS Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 15, 2024
- Completion date
- December 30, 2024
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyponatremia, siadh